New Models Aid Understanding, Treatment of Brain Disorders miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have updated their coverage on the stock in the […]
Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus rating of “Buy” from the seven brokerages that are presently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have covered the stock in the last year is $45.30. […]
uniQure (NASDAQ:QURE – Get Free Report) has received a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock in the last […]
~ Announced FDA clearance of Investigational New Drug application for AMT-260 in refractory mesial temporal lobe epilepsy ~ ~ On track to provide clinical update from U.S. and European Phase I/II.